These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 32952737)

  • 1. Pathologic Shear and Elongation Rates Do Not Cause Cleavage of Von Willebrand Factor by ADAMTS13 in a Purified System.
    Bortot M; Sharifi A; Ashworth K; Walker F; Cox A; Ruegg K; Clendenen N; Neeves KB; Bark D; Di Paola J
    Cell Mol Bioeng; 2020 Aug; 13(4):379-390. PubMed ID: 32952737
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Turbulent Flow Promotes Cleavage of VWF (von Willebrand Factor) by ADAMTS13 (A Disintegrin and Metalloproteinase With a Thrombospondin Type-1 Motif, Member 13).
    Bortot M; Ashworth K; Sharifi A; Walker F; Crawford NC; Neeves KB; Bark D; Di Paola J
    Arterioscler Thromb Vasc Biol; 2019 Sep; 39(9):1831-1842. PubMed ID: 31291760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathologic von Willebrand factor degradation with a left ventricular assist device occurs via two distinct mechanisms: mechanical demolition and enzymatic cleavage.
    Bartoli CR; Restle DJ; Zhang DM; Acker MA; Atluri P
    J Thorac Cardiovasc Surg; 2015 Jan; 149(1):281-9. PubMed ID: 25439775
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Shear stress and von Willebrand factor in health and disease.
    Tsai HM
    Semin Thromb Hemost; 2003 Oct; 29(5):479-88. PubMed ID: 14631548
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ADAMTS13 inhibition to treat acquired von Willebrand syndrome during mechanical circulatory support device implantation.
    Deconinck SJ; Nix C; Barth S; Bennek-Schöpping E; Rauch A; Schelpe AS; Roose E; Feys HB; Pareyn I; Vandenbulcke A; Muia J; Vandenbriele C; Susen S; Meyns B; Tersteeg C; Jacobs S; De Meyer SF; Vanhoorelbeke K
    J Thromb Haemost; 2022 Dec; 20(12):2797-2809. PubMed ID: 36128768
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stress and Exposure Time on von Willebrand Factor Degradation.
    Jhun CS; Siedlecki C; Xu L; Lukic B; Newswanger R; Yeager E; Reibson J; Cysyk J; Weiss W; Rosenberg G
    Artif Organs; 2019 Feb; 43(2):199-206. PubMed ID: 30374981
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Von Willebrand factor in aortic or mitral valve stenosis and bleeding after heart valve surgery.
    Mazur P; Natorska J; Ząbczyk M; Krzych Ł; Litwinowicz R; Kędziora A; Kapelak B; Undas A
    Thromb Res; 2021 Feb; 198():190-195. PubMed ID: 33360153
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in von Willebrand factor-cleaving protease (ADAMTS-13) in patients with aortic stenosis undergoing valve replacement or balloon valvuloplasty.
    Bander J; Elmariah S; Aledort LM; Dlott J; Stelzer P; Halperin JL; Kini AS; Sharma SK
    Thromb Haemost; 2012 Jul; 108(1):86-93. PubMed ID: 22627470
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patients with aortic stenosis have von Willebrand factor abnormalities and increased proliferation of endothelial colony forming cells.
    Selvam SN; Bowman M; Inglis M; Kloosterman R; Grabell J; Casey L; Johri AM; James P
    J Thromb Haemost; 2020 Mar; 18(3):593-603. PubMed ID: 31860769
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High shear dependent von Willebrand factor self-assembly fostered by platelet interaction and controlled by ADAMTS13.
    Kragh T; Napoleone M; Fallah MA; Gritsch H; Schneider MF; Reininger AJ
    Thromb Res; 2014 Jun; 133(6):1079-87. PubMed ID: 24681085
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Continuum Model for the Unfolding of von Willebrand Factor.
    Zhussupbekov M; Méndez Rojano R; Wu WT; Massoudi M; Antaki JF
    Ann Biomed Eng; 2021 Sep; 49(9):2646-2658. PubMed ID: 34401970
    [TBL] [Abstract][Full Text] [Related]  

  • 12. von Willebrand Factor Abnormalities and Heyde Syndrome in Dysfunctional Heart Valve Prostheses.
    Blackshear JL; McRee CW; Safford RE; Pollak PM; Stark ME; Thomas CS; Rivera CE; Wysokinska EM; Chen D
    JAMA Cardiol; 2016 May; 1(2):198-204. PubMed ID: 27437891
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modeling the cleavage of von Willebrand factor by ADAMTS13 protease in shear flow.
    Huisman B; Hoore M; Gompper G; Fedosov DA
    Med Eng Phys; 2017 Oct; 48():14-22. PubMed ID: 28734872
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Acquired von Willebrand syndrome].
    Hayakawa M; Matsumoto M
    Rinsho Ketsueki; 2020; 61(7):809-817. PubMed ID: 32759569
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acquired von Willebrand syndrome in aortic stenosis.
    Vincentelli A; Susen S; Le Tourneau T; Six I; Fabre O; Juthier F; Bauters A; Decoene C; Goudemand J; Prat A; Jude B
    N Engl J Med; 2003 Jul; 349(4):343-9. PubMed ID: 12878741
    [TBL] [Abstract][Full Text] [Related]  

  • 16. von Willebrand factor disruption and continuous-flow circulatory devices.
    Proudfoot AG; Davidson SJ; Strueber M
    J Heart Lung Transplant; 2017 Nov; 36(11):1155-1163. PubMed ID: 28756118
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of ADAMTS-13 by Doxycycline Reduces von Willebrand Factor Degradation During Supraphysiological Shear Stress: Therapeutic Implications for Left Ventricular Assist Device-Associated Bleeding.
    Bartoli CR; Kang J; Restle DJ; Zhang DM; Shabahang C; Acker MA; Atluri P
    JACC Heart Fail; 2015 Nov; 3(11):860-9. PubMed ID: 26454844
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acquired von Willebrand Syndrome Associated with Cardiovascular Diseases.
    Horiuchi H; Doman T; Kokame K; Saiki Y; Matsumoto M
    J Atheroscler Thromb; 2019 Apr; 26(4):303-314. PubMed ID: 30867356
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acquired von Willebrand Syndrome Hiding Inherited von Willebrand Disease Can Explain Severe Bleeding in Patients With Aortic Stenosis.
    Casonato A; Galletta E; Cella G; Barbon G; Daidone V
    Arterioscler Thromb Vasc Biol; 2020 Sep; 40(9):2187-2194. PubMed ID: 32640909
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased cleavage of von Willebrand factor by ADAMTS13 may contribute strongly to acquired von Willebrand syndrome development in patients with essential thrombocythemia.
    Kubo M; Sakai K; Hayakawa M; Kashiwagi H; Yagi H; Seki Y; Hasegawa A; Tanaka H; Amano I; Tomiyama Y; Matsumoto M
    J Thromb Haemost; 2022 Jul; 20(7):1589-1598. PubMed ID: 35352474
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.